Healthcare Pharmaceutical Biotech

AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project

June 9, 2026 1:30 AM

AlzeCure Pharma AB (publ) ("AlzeCure")(STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, announced today that the company has entered into a collaboration and out-licensing agreement with the pharmaceutical company Eli Lilly and Company ("Lilly") regarding the global rights to the Alzheimer's project Alzstatin ACD680. AlzeCure will receive an upfront payment of $10...

Read more

Marijuana Isn't Medicine Until Someone Proves It Is

June 8, 2026 10:11 PM

For years, the marijuana industry has used a powerful word to build public support, attract investors, and justify sweeping regulatory changes. That word is medicine. It appears in political speeches, investor presentations, dispensary marketing materials, state licensing programs, and now increasingly in federal policy discussions surrounding marijuana rescheduling and hemp-derived cannabinoid products. But amid the excitement surrounding...

Read more

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

June 8, 2026 7:01 PM

The University of Oxford and Moderna, Inc. (NASDAQ:MRNA) today announced a Phase 1/2 study of mRNA-4194, Moderna's investigational mRNA-based cancer vaccine for Lynch Syndrome, has received Medicines and Healthcare products Regulatory Agency (MHRA) authorization in the UK. Lynch syndrome is an inherited condition that increases cancer risk. It is caused by alterations in genes responsible for repairing DNA, leading cells to accumulate DNA errors...

Read more

Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders

June 8, 2026 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's May 22, 2026 Annual Meeting of Stockholders (the "Annual Meeting"), which was adjourned until June 8, 2026. Five proposals were submitted to and approved by the stockholders of the Company at the Annual Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Annual...

Read more

Black Book Research Releases 2026 Hospital RCM Evaluation, Naming Top Vendors Across 49 Revenue Cycle Management Categories

June 8, 2026 12:45 PM

Black Book Research today announced the 2026 Hospital Revenue Cycle Management Evaluation, identifying top-rated vendors across 49 revenue cycle management technology and services categories. The new evaluation framework reflects a decisive shift in how hospitals, health systems and inpatient provider organizations assess RCM partners: by workflow, operating risk, buyer use case and measurable financial impact, rather than by broad vendor labels...

Read more

"Three Women and Me" Set to Transform Health Media with Fearless Conversations, Renowned Experts, and a Mission to Change Lives

June 8, 2026 11:25 AM

In a world overflowing with health information yet lacking meaningful, honest dialogue, a powerful new television talk show and podcast is preparing to become a trusted voice in healthcare, wellness, and human connection. Three Women and Me, a groundbreaking new one-hour series hosted by Charles Mattocks, Dr. Angela Fisher, Dr. Cathleen Gerenger, and Heather Reilly Hiemstra, will bring together four distinct voices with one shared mission: to...

Read more

Vanna Health Appoints Dr. Liz Kwo as Chief Executive Officer, Names Giovanni Colella Executive Chairman

June 8, 2026 10:00 AM

Vanna Health, a value-based health technology company that provides integrated mental and chronic health support through community-based coaching, today announced the appointment of Dr. Liz Kwo as Chief Executive Officer, effective immediately. Dr. Giovanni Colella, who co-founded Vanna Health and has led the company since its inception, will transition to the role of Executive Chairman, where he will remain actively engaged in strategy,...

Read more

CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment

June 8, 2026 9:15 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor "What This Means" Segment. Steve O'Loughlin, Chief Financial Officer of CNS Pharmaceuticals, discussed the Company's recently completed oversubscribed $22.5 million financing in the virtual segment,...

Read more

Global Medical Response + Avel eCare Partner to Reimagine 911 Access for Rural America

June 8, 2026 9:00 AM

Two nationally recognized leaders in healthcare innovation - Global Medical Response (GMR) and Avel eCare - today announced a strategic partnership to launch 911 REACT (Rural Emergency Access, Care & Telehealth), an integrated 911-to-clinical-care access model for rural America, where distance and workforce constraints can delay medical care. "For too long, the default has been an ambulance and the emergency department," said GMR Chief Operating...

Read more

Helping Medicare Members Improve Access to Care, One Call at a Time

June 8, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Key points Debbie Kim, a Health Coach nurse on the Social Risk Factors team, helps Medicare members overcome both clinical and social barriers to care. Through patient listening, care coordination and problem solving, she uncovers deeper needs and connects members to resources that improve health and reduce costs. By meeting members where they are, Debbie builds trust and helps people take...

Read more

MDCE's Infinite Auctions Introduces New Auction Platform Combining Straight Bidding with Real-Time Buy It Now Functionality

June 8, 2026 8:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of a redesigned Infinite Auctions next generation auction platform (https://infiniteauctions.com) as the company prepares to compete for increased market share in the multi-billion dollar sports collectibles market. The upcoming NBA Game Used Flash Auction 2026 is scheduled to begin June 27, 2026 and conclude July 18, 2026. The updated disruptive platform introduces a...

Read more

As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies

June 8, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides announces that it has proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus to the Committee in Charge in the Democratic Republic of Congo (DRC). The rare Bundibugyo strain of Ebola virus causing the current outbreak appears to be its new...

Read more

AGS Health(R) Launches InnovationWorks(TM) to Turn the Promise of Revenue Cycle AI and Automation into Outcomes That Matter to Providers

June 8, 2026 8:00 AM

AGS Health®, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., announced today the launch of AGS Health InnovationWorks™. This center of excellence is purpose-built to turn the promise of revenue cycle AI into outcomes that matter to providers: stronger financial performance, better patient financial experience, and the freedom to invest in care....

Read more

GEN Announces First Patient Dosed in Phase II Clinical Trial of SUL-238 in Parkinson's Disease

June 8, 2026 8:00 AM

GEN Pharmaceuticals (GENIL.IS), Türkiye's leading specialty pharmaceutical company, announced today that the first patient has been dosed in its Phase II Proof of Concept Trial for SUL-238 Targeting Mitochondrial Dysfunction in Patients with Parkinson's Disease. Details of the Phase II trial, entitled "A Phase II, Randomized, Double-blind, Placebo-Controlled, Single-Center Study to Assess the effects of SUL-238 on High Energy Phosphates with...

Read more

Black Book Names 2026 Top Client-Rated Hospital & Health System Revenue Cycle Management Vendors by Category

June 8, 2026 7:00 AM

Black Book Research releases its 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report, naming the top-industry client-rated revenue cycle management software, services and technology-enabled operations vendors across hospital finance, patient access, denials, prior authorization, claims, revenue integrity, AI, analytics, patient payments and managed RCM operations. One of Black Book's most anticipated...

Read more

May Monthly Letter: Continued Scaling and Increased Utilisation

June 8, 2026 6:20 AM

iZafe Group (STO:IZAFE-B) - May was a month in which we continued to build on the foundation established during the spring. Following the entry into force of the ADDA agreement and increased activity across several markets, our focus is now on methodically converting pipeline, customer dialogues and procurements into concrete implementations and more active units. The number of active Dosell units increased by approximately 4 percent compared...

Read more

Marijuana Rescheduling or Regulatory Failure? D.C. Appellate Court Will Rule

June 7, 2026 10:10 AM

On April 28, 2026, the Acting Attorney General of the United States signed a single order that changed the legal status of marijuana in America - effective the same day it was published, without a public comment period, without a congressional vote, and without completing the formal scientific hearing that federal law requires. Within days, three separate legal challenges had been filed in the federal courts. Today, all of them are headed...

Read more

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program

June 5, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a non-binding Letter of Intent ("LOI") with Nanosoft Polymers ("Nanosoft"), a biotechnology-focused polymer company, as an initial step toward negotiating a services agreement related to polymer process development, analytical characterization, and drug formulation optimization activities for...

Read more

Icarus Behavioral Health Nevada Expands its Integrated Inpatient Rehab Programs for Gambling Addiction

June 5, 2026 4:32 PM

Icarus Behavioral Health Nevada is raising awareness of its integrated treatment services for adults facing gambling addiction alongside mental health and substance use concerns, offering structured care for a growing need in Las Vegas, across Nevada, and throughout the nation. Source: Icarus Behavioral Health Nevada (EZ Newswire) Gambling addiction can affect finances, relationships, employment, emotional stability, and overall well-being. For...

Read more

Breaking !! CMS Hemp Program Appeal Filed in Federal Appellate Court

June 5, 2026 11:45 AM

MMJ International Holdings, Inc. ("MMJ"), Smart Approaches to Marijuana ("SAM"), and a coalition of public health, pharmaceutical, and community organizations have formally appealed the dismissal of their lawsuit challenging the Centers for Medicare & Medicaid Services' ("CMS") controversial hemp-derived cannabinoid program. The Notice of Appeal, filed with the U.S. Court of Appeals for the District of Columbia Circuit, seeks review of a...

Read more